Search results
Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
Benzinga via Yahoo Finance· 1 year agoGenentech, a unit of Roche Holdings AG (OTC: RHHBY), announced that the Phase 3 IMbrave050 study met...
Google AI-Powered Chatbot's Ethical Concerns, MGM Hackers Waited For Days Before Issuing Financial...
Benzinga via Yahoo Finance· 8 months agoBloomberg Google's AI Dilemma - Bard's Promise Versus Ethical Concerns Alphabet Inc (NASDAQ: GOOG)...
Replimune Shares Surge After Early Data From Pretreated Melanoma Patients
Benzinga via Yahoo Finance· 2 years agoReplimune Group Inc (NASDAQ: REPL) announced initial data from the first 75 patients from the...
Roche (RHHBY) Announces Data on Tecentriq Combo for HCC
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) new data from the late-stage IMbrave050 study reveals that the combination of...
Replimune (REPL) Gains on Positive Data From Melanoma Study
Zacks via Yahoo Finance· 2 weeks agoReplimune's (REPL) lead pipeline candidate RP1, in combination with Opdivo, leads to an overall...
Tempest (TPST) Up as First-Line Liver Cancer Study Meets Goals
Zacks via Yahoo Finance· 8 months agoTempest (TPST) skyrockets 2879% on positive new and updated findings from its early-mid-stage study...
First-Line Treatment for Lung Cancer
Verywell Health via Yahoo News· 2 years agoWhen you are diagnosed with lung cancer, the preferred initial treatment is called the first-line treatment. It may also be referred to as induction...
